Adherence Monitoring: Digital and Child-Resistant
With Schreiner MediPharm’s Smart Blister Wallets, medication adherence in clinical trials can be monitored digitally and in real time. Supported by its partner Keystone, a leading US designer and manufacturer of pharmaceutical paperboard packaging, Schreiner MediPharm is now extending its
Investigational Drug or Placebo – Blinding with Transparency
To ensure that clinical trial participants don’t know whether they are receiving the investigational drug or merely a placebo, the substances must be indistinguishable from each other. Schreiner MediPharm has developed a reliable blinding solution for vials used for clinical
Concentrated Expertise: Packaging Seminar
In the middle of September 2023, the two packaging specialists SGD Pharma and Schreiner MediPharm jointly conducted a two-day seminar to provide participants from the pharmaceutical industry with insights into glass and label manufactur¬ing and to inform them about current
mRNA Substances: Deep-freeze Label plus Light Protection
Novel therapies and vaccines based on mRNA substances as well as cell and gene therapies are becoming increasingly important , but these active pharmaceutical ingredients (APIs) are particularly sensitive. They are stored and transported on dry ice at temperatures of
Smart Adherence Monitoring: Digitally Documented
Due to aging populations, the number of patients who are prescribed several drugs at the same time is increasing. In addition, the need for personal visits to doctor’s offices is declining as patients increasingly receive digital care and home deliveries
Practical and Space-Saving: Mini-Cap-Lock Secures Glass Syringe
Cap-Lock, the innovative solution from Schreiner MediPharm for protecting the integrity of Luer Lock COC syringes, is now being adapted for use also on glass syringes. The novel “Mini-Cap-Lock” security concept is based on a small cap adapter that is
Healthcare: RFID/NFC-Trends
Digital patient health and automated processes in hospital settings are becoming increasingly important. RFID-based solutions assume an important role in that regard. Frederic Vicentini and Sylvia Kaiser-Kershaw from our RFID partner company NXP® Semiconductors and Arne Rehm from Schreiner MediPharm
Strong Partners for Sustainability: Alliance to Zero
The Alliance to Zero (A2Z) was founded by eight companies along the pharma supply chain to support the transition of the pharmaceutical industry to net-zero emissions. Besides Ypsomed and Schreiner MediPharm, Dätwyler, Harro Höfliger, HealthBeacon, Körber Pharma, SCHOTT, and Sharp
Closure Seals: Custom-Fit Solutions for Any Requirement
Around 200 billion U.S. dollars: That is the value of the worldwide market for faked medicines—and it keeps growing by about 20 percent per year—about twice as fast as the legal market for medicines: Reason enough for pharmaceutical companies to
Customized Services: Agile and Efficient Supply Chain
Country-specific regulations, various languages, and special packaging formats—a reliable and efficient supply chain poses special challenges to pharmaceutical manufacturers and their suppliers. In addition, increasing specialization of drugs—for instance in the area of personalized medicine—as well as the demand for